{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T11:51:31Z","timestamp":1774007491208,"version":"3.50.1"},"reference-count":62,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2014,4,30]],"date-time":"2014-04-30T00:00:00Z","timestamp":1398816000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0095461","type":"journal-article","created":{"date-parts":[[2014,4,30]],"date-time":"2014-04-30T20:10:36Z","timestamp":1398888636000},"page":"e95461","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":78,"title":["Bimatoprost-Loaded Ocular Inserts as Sustained Release Drug Delivery Systems for Glaucoma Treatment: In Vitro and In Vivo Evaluation"],"prefix":"10.1371","volume":"9","author":[{"given":"Ju\u00e7ara Ribeiro","family":"Franca","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giselle","family":"Foureaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo Lima","family":"Fuscaldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana Gomes","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00edvia Bomfim","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata","family":"Bravo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel Oliveira","family":"Castilho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Irene","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valbert Nascimento","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone Od\u00edlia","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebasti\u00e3o","family":"Cronemberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anderson Jos\u00e9","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9 Augusto Gomes","family":"Faraco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,4,30]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/S0140-6736(04)16257-0","article-title":"Primary open-angle glaucoma","volume":"363","author":"RN Weinreb","year":"2004","journal-title":"The Lancet"},{"key":"ref2","first-page":"S20","article-title":"Current management of glaucoma and the need for complete therapy","volume":"14","author":"SJ McKinnon","year":"2008","journal-title":"Am J Manag Care"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"197","DOI":"10.4103\/0253-7613.44151","article-title":"Recent advances in pharmacotherapy of glaucoma","volume":"40","author":"SK Gupta","year":"2008","journal-title":"Indian Journal of Pharmacology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1590\/S0001-37652009000300017","article-title":"Visual impairment and blindness: an overview of prevalence and causes in Brazil","volume":"81","author":"SR Salomao","year":"2009","journal-title":"Anais Da Academia Brasileira De Ciencias"},{"key":"ref5","first-page":"844","article-title":"Global data on visual impairment in the year 2002","volume":"82","author":"S Resnikoff","year":"2004","journal-title":"Bulletin of the World Health Organization"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/IJG.0b013e31806540a1","article-title":"Risk factors and open-angle glaucoma: Classification and application","volume":"16","author":"MV Boland","year":"2007","journal-title":"Journal of Glaucoma"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.survophthal.2008.08.006","article-title":"Risk Factors for Glaucoma Onset and Progression","volume":"53","author":"AL Coleman","year":"2008","journal-title":"Survey of Ophthalmology"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijpharm.2011.05.047","article-title":"In vitro and in vivo evaluation of an intraocular implant for glaucoma treatment","volume":"415","author":"MV Natu","year":"2011","journal-title":"International Journal of Pharmaceutics"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Bouhenni RA, Dunmire J, Sewell A, Edward DP (2012) Animal Models of Glaucoma. Journal of Biomedicine and Biotechnology.","DOI":"10.1155\/2012\/692609"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1442-9071.2012.02773.x","article-title":"Definition of glaucoma: clinical and experimental concepts","volume":"40","author":"RJ Casson","year":"2012","journal-title":"Clinical and Experimental Ophthalmology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jcjo.2012.02.003","article-title":"Epidemiology of glaucoma: what&apos;s new?","volume":"47","author":"C Cook","year":"2012","journal-title":"Canadian Journal of Ophthalmology-Journal Canadien D Ophtalmologie"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.3129\/i09.080","article-title":"Canadian Ophthalmological Society evidence-based clinical practice guidelines for the management of glaucoma in the adult eye Canadian Ophthalmological Society Glaucoma Clinical Practice Guideline Expert Committee","volume":"44","author":"PE Rafuse","year":"2009","journal-title":"Canadian Journal of Ophthalmology-Journal Canadien D Ophtalmologie"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/j.survophthal.2008.08.012","article-title":"Commercially Available Prostaglandin Analogs for the Reduction of Intraocular Pressure: Similarities and Differences","volume":"53","author":"GW Bean","year":"2008","journal-title":"Survey of Ophthalmology"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejphar.2013.01.038","article-title":"Bimatoprost protects retinal neuronal damage via Akt pathway","volume":"702","author":"N Takano","year":"2013","journal-title":"European Journal of Pharmacology"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"S347","DOI":"10.1016\/S0039-6257(01)00213-2","article-title":"Mechanism of action of bimatoprost (Luminan (TM))","volume":"45","author":"RF Brubaker","year":"2001","journal-title":"Survey of Ophthalmology"},{"key":"ref16","first-page":"413","article-title":"A historical perspective and recent advances in prostamide research and therapeutics","volume":"10","author":"RM Burk","year":"2007","journal-title":"Current Opinion in Drug Discovery & Development"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"S337","DOI":"10.1016\/S0039-6257(01)00224-7","article-title":"The pharmacology of bimatoprost (Lumigan (TM))","volume":"45","author":"DF Woodward","year":"2001","journal-title":"Survey of Ophthalmology"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/bjp.2008.142","article-title":"Identification and pharmacological characterization of the prostaglandin FP receptor and FP receptor variant complexes","volume":"154","author":"Y Liang","year":"2008","journal-title":"British Journal of Pharmacology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1089\/108076803762718105","article-title":"Hydrolysis of bimatoprost (Lumigan) to its free acid by ocular tissue in vitro","volume":"19","author":"SS Davies","year":"2003","journal-title":"Journal of Ocular Pharmacology and Therapeutics"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijpharm.2004.11.033","article-title":"Dispersion of microemulsion drops in HEMA hydrogel: a potential ophthalmic drug delivery vehicle","volume":"292","author":"D Gulsen","year":"2005","journal-title":"International Journal of Pharmaceutics"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.addr.2005.07.005","article-title":"The use of mucoadhesive polymers in ocular drug delivery","volume":"57","author":"A Ludwig","year":"2005","journal-title":"Advanced Drug Delivery Reviews"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/IJG.0b013e31814b990d","article-title":"Barriers to glaucoma drug delivery","volume":"17","author":"D Ghate","year":"2008","journal-title":"Journal of Glaucoma"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.exer.2013.04.007","article-title":"Biodegradable nanoparticles for controlled subconjunctival delivery of latanoprost acid: In vitro and in vivo evaluation. Preliminary results","volume":"112","author":"A Giarmoukakis","year":"2013","journal-title":"Experimental Eye Research"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ijpharm.2004.10.026","article-title":"Improved pharmacodynamics of timolol maleate from a mucoadhesive niosomal ophthalmic drug delivery system","volume":"290","author":"D Aggarwal","year":"2005","journal-title":"International Journal of Pharmaceutics"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1007\/s11095-010-0159-x","article-title":"Biodegradable Implants for Sustained Drug Release in the Eye","volume":"27","author":"SS Lee","year":"2010","journal-title":"Pharmaceutical Research"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1208\/s12249-011-9701-3","article-title":"Biodegradable Ocular Inserts for Sustained Delivery of Brimonidine Tartarate: Preparation and In Vitro\/In Vivo Evaluation","volume":"12","author":"MH Aburahma","year":"2011","journal-title":"Aaps Pharmscitech"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1586\/erd.09.4","article-title":"Drug delivery systems for the eye","volume":"6","author":"VR Kearns","year":"2009","journal-title":"Expert Review of Medical Devices"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.2174\/138955709791012292","article-title":"Chitosan and its Role in Ocular Therapeutics","volume":"9","author":"S Wadhwa","year":"2009","journal-title":"Mini-Reviews in Medicinal Chemistry"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1773-2247(10)50005-4","article-title":"Chitosan and its derivatives as intraocular penetration enhancers","volume":"20","author":"Y Zambito","year":"2010","journal-title":"Journal of Drug Delivery Science and Technology"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0144-8617(94)90115-5","article-title":"RELATIONSHIPS BETWEEN THE CHAIN FLEXIBILITIES OF CHITOSAN MOLECULES AND THE PHYSICAL-PROPERTIES OF THEIR CASTED FILMS","volume":"24","author":"RH Chen","year":"1994","journal-title":"Carbohydrate Polymers"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0378-5173(99)00003-4","article-title":"Topical use of chitosan in ophthalmology: tolerance assessment and evaluation of precorneal retention","volume":"180","author":"O Felt","year":"1999","journal-title":"International Journal of Pharmaceutics"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0378-5173(98)00277-4","article-title":"The enhancement of the bioadhesive properties of calcium alginate gel beads by coating with chitosan","volume":"175","author":"O Gaserod","year":"1998","journal-title":"International Journal of Pharmaceutics"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2006.04.017","article-title":"Polyionic hydrocolloids for the intestinal delivery of protein drugs: Alginate and chitosan - a review","volume":"114","author":"M George","year":"2006","journal-title":"Journal of Controlled Release"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1016\/j.addr.2005.07.004","article-title":"The use of mucoadhesive polymers in vaginal delivery","volume":"57","author":"C Valenta","year":"2005","journal-title":"Advanced Drug Delivery Reviews"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2008.09.047","article-title":"In vitro release and characterization of chitosan films as dexamethasone carrier","volume":"368","author":"LB Rodrigues","year":"2009","journal-title":"International Journal of Pharmaceutics"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ijpharm.2008.03.005","article-title":"Formulation of monolayered films with drug and polymers of opposing solubilities","volume":"358","author":"VA Perumal","year":"2008","journal-title":"International Journal of Pharmaceutics"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/03639040600713134","article-title":"Chitosan formulations for steroid delivery: Effect of formulation variables on in vitro characteristics","volume":"33","author":"H Eroglu","year":"2007","journal-title":"Drug Development and Industrial Pharmacy"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1208\/s12249-009-9288-0","article-title":"A Novel Itraconazole Bioadhesive Film for Vaginal Delivery: Design, Optimization, and Physicodynamic Characterization","volume":"10","author":"NB Dobaria","year":"2009","journal-title":"Aaps Pharmscitech"},{"key":"ref39","unstructured":"(BRASIL) ANDVS, CRUZ FO (2010) Farmacopeia brasileira. Bras\u00edlia: ANVISA: FIOCRUZ."},{"key":"ref40","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0969-8043(02)00197-5","article-title":"Technetium-99m labeling of tityustoxin and venom from the scorpion Tityus serrulatus","volume":"57","author":"EA Nunan","year":"2002","journal-title":"Applied Radiation and Isotopes"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1016\/j.apradiso.2012.06.022","article-title":"Kit formulation for 99mTc-labeling of HYNIC-\u03b2Ala-Bombesin(7\u201314)","volume":"70","author":"ALB de Barros","year":"2012","journal-title":"Applied Radiation and Isotopes"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.exer.2005.01.008","article-title":"A new experimental model of glaucoma in rats through intracameral injections of hyaluronic acid","volume":"81","author":"MC Moreno","year":"2005","journal-title":"Experimental Eye Research"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.3390\/md8051567","article-title":"Application of Spectroscopic Methods for Structural Analysis of Chitin and Chitosan","volume":"8","author":"J Kumirska","year":"2010","journal-title":"Marine Drugs"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1021\/bm070014y","article-title":"Interactions between alginate and chitosan biopolymers characterized using FTIR and XPS","volume":"8","author":"G Lawrie","year":"2007","journal-title":"Biomacromolecules"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.tca.2004.08.014","article-title":"Thermal analysis of chitosan and its blends","volume":"427","author":"M Mucha","year":"2005","journal-title":"Thermochimica Acta"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.carbpol.2005.02.022","article-title":"Thermal analysis of chitosan based networks","volume":"62","author":"CGT Neto","year":"2005","journal-title":"Carbohydrate Polymers"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1208\/s12248-010-9183-3","article-title":"Ocular Drug Delivery","volume":"12","author":"R Gaudana","year":"2010","journal-title":"Aaps Journal"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s11095-008-9694-0","article-title":"Recent Perspectives in Ocular Drug Delivery","volume":"26","author":"R Gaudana","year":"2009","journal-title":"Pharmaceutical Research"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3390\/polym3010193","article-title":"Recent Advances in Ocular Drug Delivery Systems","volume":"3","author":"N Kuno","year":"2011","journal-title":"Polymers"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/0892-8967(94)90053-1","article-title":"Sizes and shapes of conjunctival inserts","volume":"21","author":"D Lisa Land","year":"1994","journal-title":"International Contact Lens Clinic"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1248\/cpb.44.1039","article-title":"A study of the hydrophilic cellulose matrix: Effect of drugs on swelling properties","volume":"44","author":"SP Panomsuk","year":"1996","journal-title":"Chemical & Pharmaceutical Bulletin"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4103\/0250-474X.40330","article-title":"Formulation and Characterization of Mucoadhesive Buccal Films of Glipizide","volume":"70","author":"M Semalty","year":"2008","journal-title":"Indian Journal of Pharmaceutical Sciences"},{"key":"ref53","doi-asserted-by":"crossref","unstructured":"Yuan X-B, Li H, Yuan Y-B (2006) Preparation of cholesterol-modified chitosan self-aggregated nanoparticles for delivery of drugs to ocular surface. Carbohydrate Polymers 65.","DOI":"10.1016\/j.carbpol.2006.01.020"},{"key":"ref54","unstructured":"Kuntner C, Wanek T, Hoffer M, Dangl D, Hornof M, <etal>et al<\/etal>.. (2011) Radiosynthesis and Assessment of Ocular Pharmacokinetics of I-124-Labeled Chitosan in Rabbits Using Small-Animal PET. Molecular Imaging and Biology 13."},{"key":"ref55","doi-asserted-by":"crossref","unstructured":"Gupta H, Aqil M, Khar RK, Ali A, Bhatnagar A, <etal>et al<\/etal>.. (2010) Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery. Nanomedicine-Nanotechnology Biology and Medicine 6.","DOI":"10.1016\/j.nano.2009.10.004"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3109\/1061186X.2010.504268","article-title":"Biodegradable levofloxacin nanoparticles for sustained ocular drug delivery","volume":"19","author":"H Gupta","year":"2011","journal-title":"Journal of drug targeting"},{"key":"ref57","doi-asserted-by":"crossref","unstructured":"Wilson CG, Zhu YP, Frier M, Rao LS, Gilchrist P, <etal>et al<\/etal>.. (1998) Ocular contact time of a carbomer gel (GelTears) in humans. British Journal of Ophthalmology 82.","DOI":"10.1136\/bjo.82.10.1131"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.2165\/11203210-000000000-00000","article-title":"Bimatoprost A Review of its Use in Open-Angle Glaucoma and Ocular Hypertension","volume":"26","author":"MP Curran","year":"2009","journal-title":"Drugs & Aging"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/eye.2011.82","article-title":"Novel drug delivery systems for glaucoma","volume":"25","author":"E Lavik","year":"2011","journal-title":"Eye"},{"key":"ref60","unstructured":"Robinson MR, Burke J, Schiffman R Treating ocular condition e.g. glaucoma, comprises providing biodegradable sustained release implants containing therapeutic agent e.g. bimatoprost and latanoprost and implanting the implants into the anterior chamber of an eye. Allergan Inc."},{"key":"ref61","first-page":"123","article-title":"Nanomedicine for glaucoma: liposomes provide sustained release of latanoprost in the eye","volume":"7","author":"JV Natarajan","year":"2012","journal-title":"International Journal of Nanomedicine"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.2147\/OPTH.S48766","article-title":"Ocular pharmacokinetics of bimatoprost formulated in DuraSite compared to bimatoprost 0.03% ophthalmic solution in pigmented rabbit eyes","volume":"7","author":"A Shafiee","year":"2013","journal-title":"Clinical Ophthalmology"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0095461","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,10]],"date-time":"2019-08-10T01:14:25Z","timestamp":1565399665000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0095461"}},"subtitle":[],"editor":[{"given":"Thomas","family":"Claudepierre","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,4,30]]},"references-count":62,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2014,4,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0095461","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,30]]}}}